Application of 21-Gene test in adjuvant radiotherapy for early breast cancer
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 3
Abstract
Breast cancer is the most common malignant tumor in women. With the development of genomics technology and medical frontier technology, the systemic treatment of breast cancer has gradually entered the era of personalized medicine. However, the decision-making of adjuvant radiotherapy for breast cancer still mainly relies on traditional clinicopathological factors, and there is a lack of scientific and reliable tools to guide precise radiotherapy in different populations. Hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative breast cancer is the most common molecular subtype of breast cancer. The 21-Gene recurrence score (RS) test (Oncotype Dx™, Genomic Health, Redwood City, CA) is a commercially available genomic test for breast cancer. In this article, we reviewed the current research evidence on the use of 21-Gene RS test for radiotherapy decision-making in HR-positive HER2-negative early breast cancer. Current clinical studies support the predictive value of 21-Gene RS test for adjuvant radiotherapy, and several large-scale prospective clinical studies in this area are underway.
Authors and Affiliations
Xiaolu TANG, Xin HUA, Lu CAO, Jiayi CHEN
<![CDATA[Current status and future perspective of hepatic artery infusion chemotherapy]]>
<![CDATA[]]>
<![CDATA[Precision surgery in diagnosis and treatment of hepatocellular carcinoma]]>
<![CDATA[]]>
Comparative efficacy of precut over a pancreatic duct stent and transpancreatic precut sphincterotomy for difficult biliary cannulation in ERCP
[Objective] To compare the efficacy of precut over a pancreatic duct stent (PPDS) and transpancreatic precut sphincterotomy (TPS) for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography (ERCP)...
Controversies and future directions of endoscope in breast surgery
Laparoscopic surgery has been widely applied in various surgical fields, demonstrating its advantages in minimally invasive procedures. However, for breast surgery, which lacks natural cavities, there remain certain cont...
Role of the spleen in patients with liver cancer and cirrhosis
The spleen is the largest lymphoid organ that can affect the immunological microenvironment in the liver via the portal system. Patients with liver cancer, often develop hypersplenism and splenomegaly from underlying cir...